Xiidra Approved; Pending Effective Date

Posted in Latest News on September 14, 2016.

At the August 19, 2016 Board of Optometry meeting, the board voted and approved the use of Xiidra (Lifitegrast ophthalmic solution 5%) for dry eyes. The formulary rule is in the process of being changed to include Lifitegrast ophthalmic solution 5%.

Until the new rule becomes effective, Florida Optometrists are not allowed to prescribe the medication. The board will place a notification on the website advising when the addition to the rule has become effective.



More Latest News

Announcement
December 14, 2023

MQA Online Services will be unavailable from Friday, December 15, at 6:00 PM to December 17, at 12:00 PM EST. Continue reading


Board Website Re-Design Survey
November 15, 2023

MQA is planning to revamp the board websites. Please take the survey to give us your recommendations by clicking the survey icon below. Survey closing Friday, 2/2/2024 at 4:30 PM ET Continue reading